Typical drugs used in medical practice have both clinical benefits as well as limitations in therapeutic effectiveness and/or patient safety.

Our mission is to serve patients by improving the therapeutic profiles of existing, proven drugs in ways that take full advantage of their strengths while overcoming their well understood limitations. By combining complementary characteristics of two or more drugs we create new products that have additive or synergistic impact.

These next-generation combination products will provide doctors with an enhanced set of treatment options that give patients the best possible experience.

For investors, our strategy offers an attractive mix of value-creation, risk profile and development timelines.